Elecsys gh and igf 1 kits

The examinations of circulating hormones were determined by each physician for evaluating various endocrine disorders. Blood collections were carefully performed in a relaxed sitting position around late morning to early afternoon time in the same way when the patients visited our clinic. The auto-analyzer system Cobas 8000 (F. Hoffmann-La Roche AG, Basel, Switzerland) was used for measuring hormone levels at the Central Laboratory of our facility. As reported previously [12 (link)], assays for plasma adrenocorticotropin (ACTH) and serum cortisol were performed by an electro-chemiluminescence immunoassay (ECLIA) using Elecsys ACTH and Elecsys Cortisol II kits (F. Hoffmann-La Roche AG), respectively. The assays for serum free-thyroxin (FT4) and thyrotropin (TSH) were performed by Elecsys FT4 III and TSH kits, and the assays for serum GH and IGF-I were completed by Elecsys GH and IGF-I kits (F. Hoffmann-La Roche AG), respectively. Serum levels of IGF-I were then calculated to the values of standard deviation (SD) [17 (link)].

Blood sampling was performed in a relaxed sitting position at the time each patient visited the CAC, which was around late morning to early afternoon. The blood tests were determined by each physician, and the measurements were performed using the Cobas 8000 auto-analyzer system (F. Hoffmann-La Roche AG, Basel, Switzerland) at the central laboratory of our facility. Assays for serum ferritin were performed by an electro-chemiluminescence immunoassay (ECLIA) using the Elecsys Ferritin kit (F. Hoffmann-La Roche AG). Assays for plasma adrenocorticotropin (ACTH) and serum cortisol were also performed by ECLIA using Elecsys ACTH and Elecsys Cortisol II kits (F. Hoffmann-La Roche AG), respectively, as previously reported [8 (link)]. Assays for serum free thyroxin (FT4) and thyrotropin (TSH) were performed using Elecsys FT4 III and TSH kits, and assays for serum growth hormone (GH) and insulin-like growth factor (IGF)-I were performed using Elecsys GH and IGF-I kits (F. Hoffmann-La Roche AG), respectively.